92
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Protecting the Last Line of Defense: Analytical Approaches for Sample Preparation and Determination of the Reserve Group of Antibiotics in the Environment

ORCID Icon & ORCID Icon

References

  • Hutchings, M.; Truman, A.; Wilkinson, B. Antibiotics: Past, Present and Future. Curr. Opin. Microbiol. 2019, 51, 72–80. DOI: 10.1016/j.mib.2019.10.008.
  • Pancu, D. F.; Scurtu, A.; Macasoi, I. G.; Marti, D.; Mioc, M.; Soica, C.; Coricovac, D.; Horhat, D.; Poenaru, M.; Dehelean, C. Antibiotics: Conventional Therapy and Natural Compounds with Antibacterial Activity-a Pharmaco-Toxicological Screening. Antibiotics (Basel) 2021, 10, 401. DOI: 10.3390/antibiotics10040401.
  • Ayukekbong, J. A.; Ntemgwa, M.; Atabe, A. N. The Threat of Antimicrobial Resistance in Developing Countries: Causes and Control Strategies. Antimicrob Resist Infect Control 2017, 6, 47. DOI: 10.1186/s13756-017-0208-x.
  • Coleman, J. P.; Smith, C. J. Microbial Resistance. In xPharm: The Comprehensive Pharmacology Reference; Elsevier: Amsterdam, Netherlands, 2007; pp 1–3. DOI: 10.1016/B978-008055232-3.60228-4.
  • Vinayamohan, P. G.; Pellissery, A. J.; Venkitanarayanan, K. Role of Horizontal Gene Transfer in the Dissemination of Antimicrobial Resistance in Food Animal Production. Curr. Opin. Food Sci. 2022, 47, 100882. DOI: 10.1016/j.cofs.2022.100882.
  • Tao, S.; Chen, H.; Li, N.; Wang, T.; Liang, W. The Spread of Antibiotic Resistance Genes In Vivo Model. Can. J. Infect. Dis. Med. Microbiol. 2022, 2022, 3348695–3348611. DOI: 10.1155/2022/3348695.
  • Low, C. X.; Tan, L. T. H.; Mutalib, N. S. A.; Pusparajah, P.; Goh, B. H.; Chan, K. G.; Letchumanan, V.; Lee, L. H. Unveiling the Impact of Antibiotics and Alternative Methods for Animal Husbandry: A Review. Antibiotics (Basel) 2021, 10, 578. DOI: 10.3390/antibiotics10050578.
  • Hosain, M. Z.; Lutful Kabir, S. M.; Kamal, M. M. Antimicrobial Uses for Livestock Production in Developing Countries. Vet World 2021, 14, 210–221. DOI: 10.14202/vetworld.2021.210-221.
  • Pokharel, S.; Shrestha, P.; Adhikari, B. Antimicrobial Use in Food Animals and Human Health: Time to Implement ‘One Health’ Approach. Antimicrob. Resist. Infect. Control 2020, 9, 181. DOI: 10.1186/s13756-020-00847-x.
  • Ventola, C. L. The Antibiotic Resistance Crisis. Part 1: Causes and Threats. P&T, 2015, 40, 227–283.
  • Majumder, M. A. A.; Rahman, S.; Cohall, D.; Bharatha, A.; Singh, K.; Haque, M.; Gittens-St Hilaire, M. Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health. Infect. Drug Resist. 2020, 13, 4713–4738. DOI: 10.2147/IDR.S290835.
  • Catalano, A.; Iacopetta, D.; Ceramella, J.; Scumaci, D.; Giuzio, F.; Saturnino, C.; Aquaro, S.; Rosano, C.; Sinicropi, M. S. Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies. Molecules 2022, 27, 616. DOI: 10.3390/molecules27030616.
  • O’Neill. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. J. Rev. Antimicrob. Resist. 2016, 7, 110. DOI: 10.4103/2045-080x.186181.
  • Cassini, A.; Högberg, L. D.; Plachouras, D.; Quattrocchi, A.; Hoxha, A.; Simonsen, G. S.; Colomb-Cotinat, M.; Kretzschmar, M. E.; Devleesschauwer, B.; Cecchini, M.; et al. Attributable Deaths and Disability-Adjusted Life-Years Caused by Infections with Antibiotic-Resistant Bacteria in the EU and the European Economic Area in 2015: A Population-Level Modelling Analysis. Lancet Infect Dis 2019, 19, 56–66. DOI: 10.1016/S1473-3099(18)30605-4.
  • Interagency Coordination Group on Antimicrobial Resistance. No Time to Wait: Securing the Future from Drug-Resistant Infections; Report to the Secretary-General of the united Nations, 2019.
  • Larsson, D. G. J.; Flach, C. F. Antibiotic Resistance in the Environment. Nat. Rev. Microbiol. 2022, 20, 257–269. DOI: 10.1038/s41579-021-00649-x.
  • Stanton, I. C.; Bethel, A.; Leonard, A. F. C.; Gaze, W. H.; Garside, R. Existing Evidence on Antibiotic Resistance Exposure and Transmission to Humans from the Environment: A Systematic Map. Environ. Evid. 2022, 11, 8. DOI: 10.1186/s13750-022-00262-2.
  • Prestinaci, F.; Pezzotti, P.; Pantosti, A. Antimicrobial Resistance: A Global Multifaceted Phenomenon. Pathog. Glob. Health 2015, 109, 309–318. DOI: 10.1179/2047773215Y.0000000030.
  • U.S. Centers for Disease Control and Prevention. Initiatives for Addressing Antimicrobial Resistance in the Environment: Current Situation and Challenges. 2018. https://wellcome.ac.uk/sites/default/files/antimicrobial-resistance-environment-report.pdf
  • Karkman, A.; Do, T. T.; Walsh, F.; Virta, M. P. J. Antibiotic-Resistance Genes in Waste Water. Trends Microbiol. 2018, 26, 220–228. DOI: 10.1016/j.tim.2017.09.005.
  • García, J.; García-Galán, M. J.; Day, J. W.; Boopathy, R.; White, J. R.; Wallace, S.; Hunter, R. G. A Review of Emerging Organic Contaminants (EOCs), Antibiotic Resistant Bacteria (ARB), and Antibiotic Resistance Genes (ARGs) in the Environment: Increasing Removal with Wetlands and Reducing Environmental Impacts. Bioresour. Technol. 2020, 307, 123228. DOI: 10.1016/j.biortech.2020.123228.
  • Sharma, V. K.; Johnson, N.; Cizmas, L.; McDonald, T. J.; Kim, H. A Review of the Influence of Treatment Strategies on Antibiotic Resistant Bacteria and Antibiotic Resistance Genes. Chemosphere 2016, 150, 702–714. DOI: 10.1016/j.chemosphere.2015.12.084.
  • Kozińska, A.; Sitkiewicz, I. „Nowe” i „Stare” Antybiotyki – Mechanizmy Działania i Strategie Poszukiwania Leków Przeciwbakteryjnych. Kosmos 2017, 66, 109–124.
  • Sharland, M.; Pulcini, C.; Harbarth, S.; Zeng, M.; Gandra, S.; Mathur, S.; Magrini, N, 21st WHO Expert Committee on Selection and Use of Essential Medicines. Classifying Antibiotics in the WHO Essential Medicines List for Optimal Use—Be AWaRe. Lancet Infect. Dis. 2018, 18, 18–20. DOI: 10.1016/S1473-3099(17)30724-7.
  • World Health Organization. WHO Model List of Essential Medicines – 22nd List (WHO/MHP/HPS/EML/2021.02). Geneva, 2021.
  • Web Annex A. World Health Organization Model List of Essential Medicines – 23rd List; (WHO/MHP/HPS/EML/2023.02): Geneva, 2023.
  • Zanichelli, V.; Sharland, M.; Cappello, B.; Moja, L.; Getahun, H.; Pessoa-Silva, C.; Sati, H.; van Weezenbeek, C.; Balkhy, H.; Simão, M.; et al. The WHO AWaRe (Access, Watch, Reserve) Antibiotic Book and Prevention of Antimicrobial Resistance. Bull. World Health Org. 2023, 101, 290–296. DOI: 10.2471/BLT.22.288614.
  • Web Annex C. WHO AWaRe (Access, Watch, Reserve) Classification of Antibiotics for Evaluation and Monitoring of Use; (WHO/MHP/HPS/EML/2023.04): Geneva, 2023.
  • Critically Important Antimicrobials for Human Medicine, 6th Revision. licence: CC BY-NC-SA 3.0; IGO: Geneva, 2019.
  • Ram, B.; Kumar, M. Correlation Appraisal of Antibiotic Resistance with Fecal, Metal and Microplastic Contamination in a Tropical Indian River, Lakes and Sewage. NPJ Clean Water 2020, 3, 1–12. DOI: 10.1038/s41545-020-0050-1.
  • Khan, F. A.; Söderquist, B.; Jass, J. Prevalence and Diversity of Antibiotic Resistance Genes in Swedish Aquatic Environments Impacted by Household and Hospital Wastewater. Front. Microbiol. 2019, 10, 688. DOI: 10.3389/fmicb.2019.00688.
  • Prioritization of Pathogens to Guide Discovery, Research and Development of New Antibiotics for Drug-Resistant Bacterial Infections, Including Tuberculosis; (WHO/EMP/IAU/2017.12): Geneva, 2017.
  • Hernando-Amado, S.; Coque, T. M.; Baquero, F.; Martínez, J. L. Defining and Combating Antibiotic Resistance from One Health and Global Health Perspectives. Nat. Microbiol. 2019, 4, 1432–1442. DOI: 10.1038/s41564-019-0503-9.
  • European Centre for Disease Prevention and Control. Antimicrobial consumption in the EU/EEA (ESAC-Net) - Annual Epidemiological Report 2021; Stockholm, 2022
  • The European Commision. COMMISSION IMPLEMENTING REGULATION (EU) 2022/1255 of 19 July 2022 designating antimicrobials or groups of antimicrobials reserved for treatment of certain infections inhumans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (OJ L 191/58, 20.07.2022); Official Journal of the European Union, 2022
  • Kumar, H.; Chen, B. H.; Kuca, K.; Nepovimova, E.; Kaushal, A.; Nagraik, R.; Bhatia, S. K.; Dhanjal, D. S.; Kumar, V.; Kumar, A.; et al. Understanding of Colistin Usage in Food Animals and Available Detection Techniques: A Review. Animals (Basel) 2020, 10, 1892. DOI: 10.3390/ani10101892.
  • Scott, A.; Pottenger, S.; Timofte, D.; Moore, M.; Wright, L.; Kukavica-Ibrulj, I.; Jeukens, J.; Levesque, R. C.; Freschi, L.; Pinchbeck, G. L.; et al. Reservoirs of Resistance: Polymyxin Resistance in Veterinary-Associated Companion Animal Isolates of Pseudomonas Aeruginosa. Vet Rec 2019, 185, 206–206. DOI: 10.1136/vr.105075.
  • European Commission. Overview Report – Member States’ One Health National Action Plans Against Antimicrobial Resistance; Directorate-General for Health and Food Safety: Luxembourg, 2022.
  • Global Database for Tracking Antimicrobial Resistance (AMR). http://www.amrcountryprogress.org/#/visualization-view. (accessed August 14, 2023)
  • Abu-Ajaleh, S.; Darwish Elhajji, F.; Al-Bsoul, S.; Abu Farha, R.; Al-Hammouri, F.; Amer, A.; Al Rusasi, A.; Al-Azzam, S.; Araydah, M.; Aldeyab, M. A. An Evaluation of the Impact of Increasing the Awareness of the WHO Access, Watch, and Reserve (AWaRe) Antibiotics Classification on Knowledge, Attitudes, and Hospital Antibiotic Prescribing Practices. Antibiotics (Basel) 2023, 12, 951–964. DOI: 10.3390/antibiotics12060951.
  • European Commission. European Union Strategic Approach to Pharmaceuticals in the Environment. Directorate-General for Environment: Brussels, 2019.
  • Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: Early Implementation 2020. licence: CC BY-NC-SA 3.0; IGO: Geneva, 2020.
  • Ferrari, F.; Sartori, M.; Milla, P. Antibiotic Adjustment in Continuous Renal Replacement Therapy. In Critical Care Nephrology, 3rd ed., Elsevier: Amsterdam, Netherlands, 2019; pp 1051–1067.el. DOI: 10.1016/B978-0-323-44942-7.00175-8.
  • Ribeiro, A. R.; Schmidt, T. C. Determination of Acid Dissociation Constants (PKa) of Cephalosporin Antibiotics: Computational and Experimental Approaches. Chemosphere 2017, 169, 524–533. DOI: 10.1016/j.chemosphere.2016.11.097.
  • Chmiel, T.; Mieszkowska, A.; Kempińska-Kupczyk, D.; Kot-Wasik, A.; Namieśnik, J.; Mazerska, Z. The Impact of Lipophilicity on Environmental Processes, Drug Delivery and Bioavailability of Food Components. Microchem. J 2019, 146, 393–406. DOI: 10.1016/j.microc.2019.01.030.
  • Babić, S.; Horvat, A. J. M.; Mutavdžić Pavlović, D.; Kaštelan-Macan, M. Determination of PKa Values of Active Pharmaceutical Ingredients. TrAC - Trends Anal. Chem 2007, 26, 1043–1061. DOI: 10.1016/j.trac.2007.09.004.
  • Qiang, Z.; Adams, C. Potentiometric Determination of Acid Dissociation Constants (PK a) for Human and Veterinary Antibiotics. Water Res 2004, 38, 2874–2890. DOI: 10.1016/j.watres.2004.03.017.
  • Avedissian, S. N.; Liu, J.; Rhodes, N. J.; Lee, A.; Pais, G. M.; Hauser, A. R.; Scheetz, M. H. A Review of the Clinical Pharmacokinetics of Polymyxin B. Antibiotics (Basel) 2019, 8, 31. DOI: 10.3390/antibiotics8010031.
  • Michalopoulos, A. S.; Falagas, M. E. Colistin: Recent Data on Pharmacodynamics Properties and Clinical Efficacy in Critically Ill Patients. Ann. Intensive Care 2011, 1, 30. DOI: 10.1186/2110-5820-1-30.
  • FDA. ZEMDRI, Prescribing Information. 2018.
  • FDA. PRIMAXIN, Prescribing Information. 2016.
  • FDA. RECARBRIO, Prescribing Information. 2019.
  • FDA. VABOMERE, Prescribing Information. 2017.
  • EMA. ZINFORO, Summary of Product Characteristics. 2017.
  • AVIR Pharma Inc. ZEVTERA - Product Monograph. 2021.
  • EMA. ZERBAXA, Summary of Product Characteristics. 2020.
  • EMA. ZAVICEFTA, Summary of Product Characteristics. 2021.
  • FDA. FETROJA, Prescribing Information. 2020.
  • FDA. DALVANCE, Prescribing Information. 2018.
  • FDA. ORBACTIV, Prescribing Information. 2021.
  • FDA. VIBATIV, Prescribing Information. 2009.
  • EMA. TYGACIL, Summary of Product Characteristics. 2016.
  • FDA. CUBICIN, Prescribing Information. 2010.
  • EMA. CAYSTON. Summary of Product Characteristics. 2016.
  • McNulty, C. A. M.; Garden, G. M. F.; Ashby, J.; Wise, R. Pharmacokinetics and Tissue Penetration of Carumonam, a New Synthetic Monobactam. Antimicrob Agents Chemother 1985, 28, 425–427. DOI: 10.1128/AAC.28.3.425.
  • FDA. ZYVOX. Prescribing Information. 2013.
  • FDA. SIVEXTRO. Prescribing Information. 2014.
  • Harada, K.; Shimizu, T.; Miyashita, N.; Hikasa, Y. Assessment of Urinary Pharmacokinetic and Pharmacodynamic Profiles of Faropenem against Extended-Spectrum β-Lactamase-Producing Escherichia Coli with Canine Ex Vivo Modelling: A Pilot Study. Access Microbiol 2019, 1, e000004. DOI: 10.1099/acmi.0.000004.
  • Dijkmans, A. C.; Zacarías, N. V. O.; Burggraaf, J.; Mouton, J. W.; Wilms, E. B.; van Nieuwkoop, C.; Touw, D. J.; Stevens, J.; Kamerling, I. M. C. Fosfomycin: Pharmacological, Clinical and Future Perspectives. Antibiotics (Basel) 2017, 6, 24. DOI: 10.3390/antibiotics6040024.
  • Mercuro, N. J.; Veve, M. P. Clinical Utility of Lefamulin: If Not Now, When? Curr. Infect. Dis. Rep. 2020, 22, 951–964. DOI: 10.1007/s11908-020-00732-z.
  • Couet, W.; Grégoire, N.; Gobin, P.; Saulnier, P. J.; Frasca, D.; Marchand, S.; Mimoz, O. Pharmacokinetics of Colistin and Colistimethate Sodium after a Single 80-Mg Intravenous Dose of CMS in Young Healthy Volunteers. Clin. Pharmacol. Ther. 2011, 89, 875–879. DOI: 10.1038/clpt.2011.48.
  • SteriMax Inc. Polymyxin B for Injection USP - Product Monograph. 2018.
  • FDA. XERAVA. Prescribing Information. 2018.
  • Saivin, S.; Houin, G. Clinical Pharmacokinetics of Doxycycline and Minocycline. Clin Pharmacokinet 1988, 15, 355–366. DOI: 10.2165/00003088-198815060-00001.
  • FDA. NUZYRA. Prescribing Information. 2018.
  • Polianciuc, S. I.; Gurzău, A. E.; Kiss, B.; Ştefan, M. G.; Loghin, F. Antibiotics in the Environment: Causes and Consequences. Med. Pharm. Rep. 2020, 93, 231–240. DOI: 10.15386/mpr-1742.
  • Liu, C.; Tan, L.; Zhang, L.; Tian, W.; Ma, L. A Review of the Distribution of Antibiotics in Water in Different Regions of China and Current Antibiotic Degradation Pathways. Front. Environ. Sci 2021, 9, 1–24. DOI: 10.3389/fenvs.2021.692298.
  • Brouwers, R.; Vass, H.; Dawson, A.; Squires, T.; Tavaddod, S.; Allen, R. J. Stability of β-Lactam Antibiotics in Bacterial Growth Media. PLoS One 2020, 15, e0236198. DOI: 10.1371/journal.pone.0236198.
  • Viaene, E.; Chanteux, H.; Servais, H.; Mingeot-Leclercq, M. P.; Tulkens, P. M. Comparative Stability Studies of Antipseudomonal β-Lactams for Potential Administration through Portable Elastomeric Pumps (Home Therapy for Cystic Fibrosis Patients) and Motor-Operated Syringes (Intensive Care Units). Antimicrob Agents Chemother 2002, 46, 2327–2332. DOI: 10.1128/AAC.46.8.2327-2332.2002.
  • Felis, E.; Kalka, J.; Sochacki, A.; Kowalska, K.; Bajkacz, S.; Harnisz, M.; Korzeniewska, E. Antimicrobial Pharmaceuticals in the Aquatic Environment - Occurrence and Environmental Implications. Eur. J. Pharmacol. 2020, 866, 172813. DOI: 10.1016/j.ejphar.2019.172813.
  • Korzeniewska, E.; Korzeniewska, A.; Harnisz, M. Antibiotic Resistant Escherichia Coli in Hospital and Municipal Sewage and Their Emission to the Environment. Ecotoxicol. Environ. Saf. 2013, 91, 96–102. DOI: 10.1016/j.ecoenv.2013.01.014.
  • Zieliński, W.; Korzeniewska, E.; Harnisz, M.; Drzymała, J.; Felis, E.; Bajkacz, S. Wastewater Treatment Plants as a Reservoir of Integrase and Antibiotic Resistance Genes – An Epidemiological Threat to Workers and Environment. Environ. Int. 2021, 156, 106641. DOI: 10.1016/j.envint.2021.106641.
  • Kokoszka, K.; Zieliński, W.; Korzeniewska, E.; Felis, E.; Harnisz, M.; Bajkacz, S. Suspect Screening of Antimicrobial Agents Transformation Products in Environmental Samples Development of LC-QTrap Method Running in Pseudo MRM Transitions. Sci. Total Environ. 2022, 808, 152114. DOI: 10.1016/j.scitotenv.2021.152114.
  • WHO Integrated Global Surveillance on ESBL-Producing E.Coli Using a “One Health” Approach: Implementation and Opportunities; World Health Organization: Geneva, 2021.
  • Seifrtová, M.; Nováková, L.; Lino, C.; Pena, A.; Solich, P. An Overview of Analytical Methodologies for the Determination of Antibiotics in Environmental Waters. Anal. Chim. Acta 2009, 649, 158–179. DOI: 10.1016/j.aca.2009.07.031.
  • Prekrasna, I.; Pavlovska, M.; Dzhulai, A.; Dykyi, E.; Alygizakis, N.; Slobodnik, J. Antibiotic Resistance in Black Sea Microbial Communities. Front. Environ. Sci 2022, 10, 823172. DOI: 10.3389/fenvs.2022.823172.
  • Xia, X.; Wang, Z.; Fu, Y.; Du, X.-D.; Gao, B.; Zhou, Y.; He, J.; Wang, Y.; Shen, J.; Jiang, H.; Wu, Y. Association of Colistin Residues and Manure Treatment with the Abundance of Mcr-1 Gene in Swine Feedlots. Environ. Int. 2019, 127, 361–370. DOI: 10.1016/j.envint.2019.03.061.
  • Voigt, A. M.; Zacharias, N.; Timm, C.; Wasser, F.; Sib, E.; Skutlarek, D.; Parcina, M.; Schmithausen, R. M.; Schwartz, T.; Hembach, N.; et al. Association between Antibiotic Residues, Antibiotic Resistant Bacteria and Antibiotic Resistance Genes in Anthropogenic Wastewater – An Evaluation of Clinical Influences. Chemosphere 2020, 241, 125032. DOI: 10.1016/j.chemosphere.2019.125032.
  • Van den Meersche, T.; Pamel, E.; Van, Poucke, C. V.; Herman, L.; Heyndrickx, M.; Rasschaert, G.; Daeseleire, E. Development, Validation and Application of an Ultra High Performance Liquid Chromatographic-Tandem Mass Spectrometric Method for the Simultaneous Detection and Quantification of Five Different Classes of Veterinary Antibiotics in Swine Manure. J. Chromatogr. A 2016, 1429, 248–257. DOI: 10.1016/j.chroma.2015.12.046.
  • Voigt, A.; Skutlarek, D.; Timm, C.; Schreiber, C.; Felder, C.; Exner, M.; Faerber, H. A. Liquid Chromatography-Tandem Mass Spectrometry as a Fast and Simple Method for the Determination of Several Antibiotics in Different Aqueous Matrices. Environ. Chem. 2020, 17, 54–74. DOI: 10.1071/EN19115.
  • Zainab, S. M.; Junaid, M.; Rehman, M. Y. A.; Lv, M.; Yue, L.; Xu, N.; Malik, R. N. First Insight into the Occurrence, Spatial Distribution, Sources, and Risks Assessment of Antibiotics in Groundwater from Major Urban-Rural Settings of Pakistan. Sci. Total Environ. 2021, 791, 148298. DOI: 10.1016/j.scitotenv.2021.148298.
  • Angeles, L. F.; Islam, S.; Aldstadt, J.; Saqeeb, K. N.; Alam, M.; Khan, M. A.; Johura, F. T.; Ahmed, S. I.; Aga, D. S. Retrospective Suspect Screening Reveals Previously Ignored Antibiotics, Antifungal Compounds, and Metabolites in Bangladesh Surface Waters. Sci. Total Environ. 2020, 712, 136285. DOI: 10.1016/j.scitotenv.2019.136285.
  • Peris-Vicente, J.; Peris-García, E.; Albiol-Chiva, J.; Durgbanshi, A.; Ochoa-Aranda, E.; Carda-Broch, S.; Bose, D.; Esteve-Romero, J. Liquid Chromatography, a Valuable Tool in the Determination of Antibiotics in Biological, Food and Environmental Samples. J. Microchem. 2022, 177, 107309. DOI: 10.1016/j.microc.2022.107309.
  • Wang, C.; Li, X.; Lv, Z.; Wang, Y.; Ke, Y.; Xia, X. Determination of Carbapenems in Water Samples by UHPLC–MS/MS. J. Sep. Sci. 2020, 43, 2321–2329. DOI: 10.1002/jssc.201901343.
  • Cavenati, S.; Carvalho, P. N.; Almeida, C. M. R.; Basto, M. C. P.; Vasconcelos, M. T. S. D. Simultaneous Determination of Several Veterinary Pharmaceuticals in Effluents from Urban, Livestock and Slaughterhouse Wastewater Treatment Plants Using a Simple Chromatographic Method. Water Sci. Technol. 2012, 66, 603–611. DOI: 10.2166/wst.2012.218.
  • Kuc, J.; Thomas, M.; Grochowalska, I.; Kulczyk, R.; Mikosz, G.; Mrózek, F.; Janik, D.; Korta, J.; Cwynar, K. Determination and Removal of Selected Pharmaceuticals and Total Organic Carbon from Surface Water by Aluminum Chlorohydrate Coagulant. Molecules 2022, 27, 5740. DOI: 10.3390/molecules27175740.
  • Kulkarni, P.; Olson, N. D.; Raspanti, G. A.; Goldstein, R. E. R.; Gibbs, S. G.; Sapkota, A.; Sapkota, A. R. Antibiotic Concentrations Decrease during Wastewater Treatment but Persist at Low Levels in Reclaimed Water. IJERPH 2017, 14, 668. DOI: 10.3390/ijerph14060668.
  • Craddock, H. A.; Panthi, S.; Rjoub, Y.; Lipchin, C.; Sapkota, A.; Sapkota, A. R. Antibiotic and Herbicide Concentrations in Household Greywater Reuse Systems and Pond Water Used for Food Crop Irrigation: West Bank, Palestinian Territories. Sci. Total Environ. 2020, 699, 134205. DOI: 10.1016/j.scitotenv.2019.134205.
  • Pena, A.; Paulo, M.; Silva, L. J. G.; Seifrtová, M.; Lino, C. M.; Solich, P. Tetracycline Antibiotics in Hospital and Municipal Wastewaters: A Pilot Study in Portugal. Anal. Bioanal. Chem. 2010, 396, 2929–2936. DOI: 10.1007/s00216-010-3581-3.
  • Kaddah, M. M. Y.; Al-Dokhmaisy, E. H.; Mansour, B.; Daabees, H. G.; Kamal, M. F. Quantification of 16 Cephalosporins in the Aquatic Environment by Liquid Chromatography-Tandem Mass Spectrometry. J. Sep. Sci. 2022, 45, 4052–4069. DOI: 10.1002/jssc.202200481.
  • Qiu, J.; Xiong, R.; Song, X.; Zhang, M.; Peng, K.; Liu, R.; He, L. Simultaneous Determination of Multiple Polypeptide Antibiotics Residues in Lake Water by Lyophilization Combined with Liquid Chromatography–Tandem Mass Spectrometry. Anal. Sci. 2021, 37, 1687–1693. DOI: 10.2116/analsci.21P037.
  • Baranowska, I.; Magiera, S.; Baranowski, J. Clinical Applications of Fast Liquid Chromatography: A Review on the Analysis of Cardiovascular Drugs and Their Metabolites. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2013, 927, 54–79. DOI: 10.1016/j.jchromb.2013.02.002.
  • Tran, N. H.; Chen, H.; Do, T. V.; Reinhard, M.; Ngo, H. H.; He, Y.; Gin,.; K. Y.; H. Simultaneous Analysis of Multiple Classes of Antimicrobials in Environmental Water Samples Using SPE Coupled with UHPLC-ESI-MS/MS and Isotope Dilution. Talanta 2016, 159, 163–173. DOI: 10.1016/j.talanta.2016.06.006.
  • Szekeres, E.; Baricz, A.; Chiriac, C. M.; Farkas, A.; Opris, O.; Soran, M.-L.; Andrei, A.-S.; Rudi, K.; Balcázar, J. L.; Dragos, N.; Coman, C. Abundance of Antibiotics, Antibiotic Resistance Genes and Bacterial Community Composition in Wastewater Effluents from Different Romanian Hospitals. Environ. Pollut. 2017, 225, 304–315. DOI: 10.1016/j.envpol.2017.01.054.
  • Le, T. H.; Ng, C.; Chen, H.; Yi, X. Z.; Koh, T. H.; Barkham, T. M. S.; Zhou, Z.; Gin, K. Y. H. Occurrences and Characterization of Antibiotic-Resistant Bacteria and Genetic Determinants of Hospital Wastewater in a Tropical Country. Antimicrob. Agents Chemother. 2016, 60, 7449–7456. DOI: 10.1128/AAC.01556-16.
  • Wang, P.; Yuan, T.; Hu, J.; Tan, Y. Determination of Cephalosporin Antibiotics in Water Samples by Optimised Solid Phase Extraction and High Performance Liquid Chromatography with Ultraviolet Detector. Int. J. Environ. Anal. Chem. 2011, 91, 1267–1281. DOI: 10.1080/03067311003778649.
  • de Barros, A. L. C.; Schmidt, F. F.; de Aquino, S. F.; Afonso, R. J. d C. F. Determination of Nine Pharmaceutical Active Compounds in Surface Waters from Paraopeba River Basin in Brazil by LTPE-HPLC-ESI-MS/MS. Environ. Sci. Pollut. Res. Int. 2018, 25, 19962–19974. DOI: 10.1007/s11356-018-2123-y.
  • Tran, N. H.; Chen, H.; Reinhard, M.; Mao, F.; Gin, K. Y. H. Occurrence and Removal of Multiple Classes of Antibiotics and Antimicrobial Agents in Biological Wastewater Treatment Processes. Water Res. 2016, 104, 461–472. DOI: 10.1016/j.watres.2016.08.040.
  • Vaz-Moreira, I.; Harnisz, M.; Abreu-Silva, J.; Rolbiecki, D.; Korzeniewska, E.; Luczkiewicz, A.; Manaia, C. M.; Plaza, G. Antibiotic Resistance in Wastewater, Does the Context Matter? Poland and Portugal as a Case Study. Crit. Rev. Environ. Sci. Technol 2022, 52, 4194–4216. DOI: 10.1080/10643389.2021.2000828.
  • Rodriguez-Mozaz, S.; Vaz-Moreira, I.; Varela Della Giustina, S.; Llorca, M.; Barceló, D.; Schubert, S.; Berendonk, T. U.; Michael-Kordatou, I.; Fatta-Kassinos, D.; Martinez, J. L.; et al. Antibiotic Residues in Final Effluents of European Wastewater Treatment Plants and Their Impact on the Aquatic Environment. Environ. Int. 2020, 140, 105733. DOI: 10.1016/j.envint.2020.105733.
  • Le, T. H.; Ng, C.; Tran, N. H.; Chen, H.; Gin, K. Y. H. Removal of Antibiotic Residues, Antibiotic Resistant Bacteria and Antibiotic Resistance Genes in Municipal Wastewater by Membrane Bioreactor Systems. Water Res. 2018, 145, 498–508. DOI: 10.1016/j.watres.2018.08.060.
  • Wang, C.; Mantilla-Calderon, D.; Xiong, Y.; Alkahtani, M.; Bashawri, Y. M.; Al Qarni, H.; Hong, P. Y. Investigation of Antibiotic Resistome in Hospital Wastewater during the COVID-19 Pandemic: Is the Initial Phase of the Pandemic Contributing to Antimicrobial Resistance? Environ. Sci. Technol. 2022, 56, 15007–15018. DOI: 10.1021/acs.est.2c01834.
  • Ory, J.; Bricheux, G.; Robin, F.; Togola, A.; Forestier, C.; Traore, O. Biofilms in Hospital Effluents as a Potential Crossroads for Carbapenemase-Encoding Strains. Sci. Total Environ. 2019, 657, 7–15. DOI: 10.1016/j.scitotenv.2018.11.427.
  • Opriş, O.; Soran, M. L.; Lung, I.; Truşcă, M. R. C.; Szoke-Nagy, T.; Coman, C. The Optimization of the Antibiotics Extraction from Wastewaters and Manure Using Box–Behnken Experimental Design. Int. J. Environ. Sci. Technol. 2017, 14, 473–480. DOI: 10.1007/s13762-016-1165-2.
  • Gago-Ferrero, P.; Bletsou, A. A.; Damalas, D. E.; Aalizadeh, R.; Alygizakis, N. A.; Singer, H. P.; Hollender, J.; Thomaidis, N. S. Wide-Scope Target Screening of >2000 Emerging Contaminants in Wastewater Samples with UPLC-Q-ToF-HRMS/MS and Smart Evaluation of Its Performance through the Validation of 195 Selected Representative Analytes. J. Hazard Mater. 2020, 387, 121712. DOI: 10.1016/j.jhazmat.2019.121712.
  • Caban, M.; Stepnowski, P. How to Decrease Pharmaceuticals in the Environment? A Review. Environ. Chem. Lett. 2021, 19, 3115–3138. DOI: 10.1007/s10311-021-01194-y.
  • Paulus, G. K.; Hornstra, L. M.; Alygizakis, N.; Slobodnik, J.; Thomaidis, N.; Medema, G. The Impact of On-Site Hospital Wastewater Treatment on the Downstream Communal Wastewater System in Terms of Antibiotics and Antibiotic Resistance Genes. Int. J. Hyg. Environ. Health 2019, 222, 635–644. DOI: 10.1016/j.ijheh.2019.01.004.
  • Patel, M.; Kumar, R.; Kishor, K.; Mlsna, T.; Pittman, C. U.; Mohan, D. Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods. Chem. Rev. 2019, 119, 3510–3673. DOI: 10.1021/acs.chemrev.8b00299.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.